Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer

  • Kawaguchi T
  • Komatsu S
  • Ichikawa D
 et al. 
  • 42


    Mendeley users who have this article in their library.
  • 103


    Citations of this article.


Several recent studies have demonstrated that microRNAs (miRNAs) are stably detectable in plasma/serum. We tested miR-221 and miR-375, which are frequently reported to be highly and poorly expressed in pancreatic cancer (PCa), as candidates for plasma biomarkers in PCa.

Author-supplied keywords

  • Biomarker
  • Pancreatic cancer
  • Plasma
  • microRNA

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free